# FDA 483 - AGC Biologics A/S - November 05, 2019

Source: https://www.globalkeysolutions.net/records/483/agc-biologics-as/b2a4ff6b-3781-49ac-b6e6-64c7fffdf2a3

> FDA 483 for AGC Biologics A/S on November 05, 2019. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: AGC Biologics A/S
- Inspection Date: 2019-11-05
- Product Type: drugs
- Office Name: Division of Clinical Evidence and Analysis 1 (Clinical Policy and Quality)

## Related Documents

- [483 - Unknown Date](https://www.globalkeysolutions.net/records/483/agc-biologics-as/d3b10697-c365-4f69-b19b-01ba5dbeae4e)
- [483 - Unknown Date](https://www.globalkeysolutions.net/records/483/agc-biologics-as/05baabb4-c134-45f5-b1af-f26b8a4af9dd)
- [EIR - Unknown Date](https://www.globalkeysolutions.net/records/eir/agc-biologics-as/993ba3f7-8913-4409-8606-a5085d93fad1)
- [EIR - Unknown Date](https://www.globalkeysolutions.net/records/eir/agc-biologics-as/d8aa83d4-bd36-4810-855a-11d3766ff74d)
- [EIR - Unknown Date](https://www.globalkeysolutions.net/records/eir/agc-biologics-as/949ec3ed-f1b8-4169-bf53-15366341b72b)

## Related Officers

- [Reyes Candau-Chacon, Ph.D, Microbiologist](https://www.globalkeysolutions.net/people/reyes-candau-chacon-phd-microbiologist/7e93758f-43c6-49cb-bd5d-c240f910802d)
- [Chih-Jung Hsu, Ph.D., Staff Fellow](https://www.globalkeysolutions.net/people/chih-jung-hsu-phd-staff-fellow/986d155a-d64e-494b-a338-7bf4e244e4b7)
- [Riley Myers, Ph.D.; Lead Biologist](https://www.globalkeysolutions.net/people/riley-myers-phd-lead-biologist/f9f7b2db-0820-4e31-95bf-27aa2b6568ea)

Company: https://www.globalkeysolutions.net/companies/agc-biologics-as/49ad0b3f-1a32-433e-b4e1-b6643981671c

Office: https://www.globalkeysolutions.net/offices/division-of-clinical-evidence-and-analysis-1-clinical-policy-and-quality/5f95da17-30bb-423f-b892-5ea041823fbd